These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33743996)

  • 1. Rare and Complex Urology: Clinical Overview of ERN eUROGEN.
    Oomen L; Leijte E; Shilhan DE; Battye M; ; Feitz WFJ
    Eur Urol; 2022 Feb; 81(2):204-212. PubMed ID: 33743996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance in ERN eUROGEN for penile, testicular, adrenal and soft tissue cancers.
    Ashley S; Shilhan D; Battye M; Meyer C; Mancini M; Ayres B; Muneer A; Albersen M; Feitz W; Langenhuijsen JF; Sangar V
    Eur J Surg Oncol; 2022 Mar; 48(3):680-686. PubMed ID: 34893364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND).
    Nanetti L; Kearney M; Boesch S; Stovickova L; Ortigoza-Escobar JD; Macaya A; Gomez-Andres D; Roze E; Molnar MJ; Wolf NI; Darling A; Vasco G; Bertini E; Indelicato E; Neubauer D; Haack TB; Sagi JC; Danti FR; Sival D; Zanni G; Kolk A; Boespflug-Tanguy O; Schols L; van de Warrenburg B; Vidailhet M; Willemsen MA; Buizer AI; Orzes E; Ripp S; Reinhard C; Moroni I; Mariotti C;
    Neurol Sci; 2024 Mar; 45(3):1007-1016. PubMed ID: 37853291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
    Talarico R; Aguilera S; Alexander T; Amoura Z; Andersen J; Arnaud L; Avcin T; Marsal Barril S; Beretta L; Bombardieri S; Bortoluzzi A; Bouillot C; Bulina I; Burmester GR; Cannizzo S; Cavagna L; Chaigne B; Cornet A; Corti P; Costedoat-Chalumeau N; Dāvidsone Z; Doria A; Fenech C; Ferraris A; Fischer-Betz R; Fonseca JE; Frank C; Gaglioti A; Galetti I; Guimarães V; Hachulla E; Holmner M; Houssiau F; Iaccarino L; Jacobsen S; Limper M; Malfait F; Mariette X; Marinello D; Martin T; Matthews L; Matucci-Cerinic M; Meyer A; Milas-Ahić J; Moinzadeh P; Montecucco C; Mouthon L; Müller-Ladner U; Nagy G; Patarata E; Pileckyte M; Pruunsild C; Rednic S; Romão VC; Schneider M; Scirè CA; Smith V; Sulli A; Tamirou F; Tani C; Taruscio D; Taulaigo AV; Tincani A; Ticciati S; Turchetti G; van Hagen PM; van Laar JM; Viera A; de Vries-Bouwstra JK; Zschocke J; Cutolo M; Mosca M
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):3-11. PubMed ID: 35349419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of clinical activities in Endo-ERN: the need for alignment of future network criteria.
    de Vries F; Bruin M; Cersosimo A; van Beuzekom CN; Ahmed SF; Peeters RP; Biermasz NR; Hiort O; Pereira AM
    Eur J Endocrinol; 2020 Aug; 183(2):141-148. PubMed ID: 32413847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
    Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
    Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.
    Casareto L; Appelman-Dijkstra NM; Brandi ML; Chapurlat R; Cormier-Daire V; Hamdy NAT; Heath KE; Horn J; Mantovani G; Mohnike K; Sousa SB; Travessa A; Wekre LL; Zillikens MC; Sangiorgi L;
    Eur J Med Genet; 2024 Apr; 68():104916. PubMed ID: 38296035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.
    Talarico R; Cannizzo S; Lorenzoni V; Marinello D; Palla I; Pirri S; Ticciati S; Trieste L; Triulzi I; Terol E; Bucher A; Turchetti G
    Orphanet J Rare Dis; 2020 Dec; 15(1):347. PubMed ID: 33317578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)].
    Schulz L; Sebode M; Schramm C; Lohse AW
    Internist (Berl); 2021 Apr; 62(4):441-448. PubMed ID: 33687527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Transition of Care for Patients with Anorectal Malformations and Hirschsprung Disease: A European Survey.
    Violani C; Grano C; Fernandes M; Prato AP; Feitz WFJ; Wijnen R; Battye M; Schwarzer N; Lemli A; Cavalieri D; Aminoff D
    Eur J Pediatr Surg; 2023 Jun; 33(3):191-197. PubMed ID: 35830861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Reference Network for Rare Neurological Diseases.
    Reinhard C; Bachoud-Lévi AC; Bäumer T; Bertini E; Brunelle A; Buizer AI; Federico A; Gasser T; Groeschel S; Hermanns S; Klockgether T; Krägeloh-Mann I; Landwehrmeyer GB; Leber I; Macaya A; Mariotti C; Meissner WG; Molnar MJ; Nonnekes J; Ortigoza Escobar JD; Pérez Dueñas B; Renna Linton L; Schöls L; Schuele R; Tijssen MAJ; Vandenberghe R; Volkmer A; Wolf NI; Graessner H
    Front Neurol; 2020; 11():616569. PubMed ID: 33519696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Educational and knowledge gaps within the European reference network on rare endocrine conditions.
    Iotova V; Schalin-Jäntti C; Bruegmann P; Broesamle M; Bratina N; Tillmann V; Hiort O; Pereira AM
    Endocr Connect; 2021 Jan; 10(1):37-44. PubMed ID: 33289690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing and boosting communication in the European Reference Network for Rare Neurological Diseases (ERN-RND): the impact of offering free educational webinars.
    Brunelle Praschberger A; Post AEM; Hermanns S; Graessner H
    Orphanet J Rare Dis; 2022 Mar; 17(1):89. PubMed ID: 35236389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of EXABO - An Expert Advisory Board for the European Reference Network for Rare Respiratory Diseases.
    Walther D; Steinmann O; Wagner TOF; Storf H
    Stud Health Technol Inform; 2020 Jun; 270():986-990. PubMed ID: 32570529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.
    Bernts LHP; Jones DEJ; Kaatee MM; Lohse AW; Schramm C; Sturm E; Drenth JPH
    Orphanet J Rare Dis; 2019 Jul; 14(1):169. PubMed ID: 31287000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERN CRANIO patient coverage of craniosynostosis in Europe.
    Spivack O; Gaillard L;
    Orphanet J Rare Dis; 2022 Sep; 17(1):333. PubMed ID: 36056364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical evaluation of the EU-virtual consultation platform (CPMS) within the European Reference Network on Rare Endocrine Conditions.
    White EK; Wagner IV; van Beuzekom C; Iotova V; Ahmed SF; Hiort O; Pereira AM
    Endocr Connect; 2022 Nov; 11(11):. PubMed ID: 36112499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-centered approaches for patients with systemic autoimmune rheumatic diseases: development and evolution.
    Vlachoyiannopoulos PG; Chatzis LG; Goules AV; Argyropoulou OD; Englezopoulou A; Stergiou I; Voulgarelis M; Tsanakas P; Exarchos T; Gorgoulis VV; Fotiadis DI; Tzioufas AG
    Expert Rev Clin Immunol; 2022 Feb; 18(2):125-133. PubMed ID: 35057695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.
    Talarico R; Ramirez GA; Barreira SC; Cardamone C; Triggianese P; Aguilera S; Andersen J; Avcin T; Benistan K; Bertsias G; Bortoluzzi A; Bouillot C; Bulina I; Burmester GR; Callens S; Carreira PE; Cervera R; Cutolo M; Damian L; Della-Torre E; Faria R; Fonseca JE; Galetti I; Hachulla E; Iaccarino L; Jacobsen S; Khmelinskii N; Limper M; Marinello D; Meyer A; Moroncini G; Nagy G; Olesinska M; Pamfil C; Pileckyte M; Pistello M; Rednic S; Richez C; Romão VC; Schneider M; Sciascia S; Scirè CA; Simonini G; Smith V; Sulli A; Tani C; Tas SW; Tincani A; Vonk MC; Tektonidou M; Mosca M
    Clin Exp Rheumatol; 2023 Mar; 41(3):543-553. PubMed ID: 36916322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.